Endovascular Treatment Market Revenue Report with Forecast to 2030

The newly published report titled "Global Endovascular Treatment Devices Market (Product (percutaneous endovascular aneurysm repair (EVAR), fenestrated EVAR, aortic stents biodegradable stents, self-expanding nitinol stents, thoracic aortic aneurysm grafts and other devices), Procedure (Ballon Angioplasty, Angioplasty With Stent Replacement, Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery, Thrombosis, Renal Artery Angioplasty and Stenting, Transfemoral Carotid Artery Revascularization, Intravascular Brachytherapy, Carotid Artery Stenting), Application (pulmonary, vascular, cardiology surgery, neurology and radiology))- By Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2030." of InsightAce Analytic Pvt. Ltd. features detailed industry analysis and an extensive study on the market, exploring its significant factors.

The global Endovascular Treatment Devices market is estimated to reach over USD 5.77 billion by 2030, exhibiting a CAGR of 8.52% during the forecast period. 

Get Free Sample Copy of Report :https://www.insightaceanalytic.com/request-sample/1364

Endovascular surgery is an advanced, minimally invasive procedure used to treat medical conditions that impact the blood arteries, such as aneurysms, bulging or "ballooning" blood vessels. The treatment begins with a body incision to gain access to the blood vessels. Then, to enable medication withdrawal or delivery from the patient's bloodstream, a flexible plastic tube, stents, or catheter is inserted into the injured blood vessel. Chemotherapy, long-term intravenous nourishment, intravenous antibiotic therapy, and blood transfusions are a few therapies that use endovascular therapeutic devices. Due to factors like an ageing population, an increase in the prevalence of cardiovascular diseases, technologically advanced endovascular products, and increased spending on research and development by market players, the market for endovascular treatment devices is predicted to expand during the forecast period.

Market expansion is being restrained by the high cost of endovascular procedures, a lack of knowledge in developing economies, and a lack of skilled surgeons to perform the functions. The use of endovascular treatment devices has expanded as a result of breakthrough product launches and rising healthcare spending, which is stimulating research and development.

List of Prominent Players in the Endovascular Treatment Devices Market:
Cardinal Health
Endospan
Geting AB
Bosten Scientific Corporation
Inspire MD
Japan Lifeline Co., Ltd.
Medtronic
Lombord Medical
Penumbra, Inc.
Terumo Corporation

Market Dynamics:
Drivers-
In the upcoming years, market growth will also be fueled by the high prevalence of abdominal aortic aneurysms, which are more common in men, and a potential rise in demand for minimally invasive techniques like endovascular surgery. The majority of abdominal aortic aneurysms (AAA), which mainly afflict men, range from 4% to 8%, according to screening studies. Due to the growing global geriatric population, AAA prevalence is high in the ageing population and could become substantial in the future. The market for endovascular treatment devices will proliferate due to rapid technological advancement and considerable improvements in minimally invasive surgery.

Challenges:
Some of the main obstacles in the global market for endovascular treatment devices are anticipated to include the high cost associated with using new endovascular therapy devices, a lack of awareness in economically underdeveloped countries, and the US's strict tax regulations on medical products.
Regional Trends:
The North America Endovascular Treatment Devices market is expected to register a significant market share in revenue and is projected to grow at a high CAGR shortly. The market has grown due to an increase in surgical operations and medical professionals' desire for these devices, which has led big businesses to concentrate on developing cutting-edge medical devices in these countries. The region's endovascular therapy devices market will grow due to the obesity and diet epidemics, as well as the development of new products due to prominent manufacturers. Besides, Asia Pacific had a substantial share in the endovascular treatment devices market. Increased medical advancements have contributed to the endovascular treatment devices market revenue growth in this area, leading to continuing industry expansion. Increased R&D efforts and medical advances made by significant participants in the region's nations can also be credited with growth.

Inquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1364

Recent Developments:
In November 2021, Endospan released 30-day and 1-year safety and performance results for its off-the-shelf endovascular Nexus graft devices, designed to treat thoracic aortic lesions involving the aortic arch.

In September 2021, Boston Scientific Corporation agreed to buy Devoro Medical, the developer of the WOLF Thrombectomy Platform, to expand its interventional techniques for thromboembolism, including the EkoSonic Endovascular System.

Segmentation of Endovascular Treatment Devices Market-
By Product-
Percutaneous Endovascular Aneurysm Repair (EVAR)
Fenestrated EVAR
Aortic Stents Biodegradable Stents
Self-Expanding Nitinol Stents
ThoracicAortic Aneurysm Grafts
Other Devices

By Procedure-
Ballon Angioplasty
Angioplasty With Stent Replacement
Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
Thrombosis
Renal Artery Angioplasty and Stenting
Transfemoral Carotid Artery Revascularization
Intravascular Brachytherapy
Carotid Artery Stenting

By Application-
Pulmonary
Vascular
Cardiology Surgery
Neurology
Radiology

By Region-
North America-
The US
Canada
Mexico

Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe

Asia-Pacific-
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific

Latin America-
Brazil
Argentina
Rest of Latin America

Middle East & Africa-
GCC Countries
South Africa
Rest of Middle East and Africa

For Customization: https://www.insightaceanalytic.com/customisation/1364

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.